Works by Miller, Rowan E.
Results: 21
Combination Systemic Therapy for Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1218, doi. 10.1634/theoncologist.2009-0105
- By:
- Publication type:
- Article
Targeted therapies in gynaecological cancers.
- Published in:
- Histopathology, 2020, v. 76, n. 1, p. 157, doi. 10.1111/his.14009
- By:
- Publication type:
- Article
Lung carcinoma with hypertrophic osteoarthropathy in a teenager.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours.
- Published in:
- BJU International, 2013, v. 111, n. 4b, p. E152, doi. 10.1111/j.1464-410X.2012.11537.x
- By:
- Publication type:
- Article
Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PARP inhibitors and immunotherapy in ovarian and endometrial cancers.
- Published in:
- British Journal of Radiology, 2021, v. 94, n. 1128, p. 1, doi. 10.1259/bjr.20210002
- By:
- Publication type:
- Article
Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1271647
- By:
- Publication type:
- Article
Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 1105, doi. 10.2147/OTT.S272199
- By:
- Publication type:
- Article
Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions.
- Published in:
- Women's Health (17455057), 2020, p. 1, doi. 10.1177/1745506520961709
- By:
- Publication type:
- Article
Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions.
- Published in:
- Women's Health (17455057), 2020, v. 16, p. 1, doi. 10.1177/1745506520961709
- By:
- Publication type:
- Article
Disparity in the era of personalized medicine for epithelial ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359221148024
- By:
- Publication type:
- Article
The Status of Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitors in Ovarian Cancer, Part 2: Extending the Scope Beyond Olaparib and BRCA1/2 Mutations.
- Published in:
- Clinical Advances in Hematology & Oncology, 2016, v. 14, n. 9, p. 704
- By:
- Publication type:
- Article
The Status of Poly(Adenosine Diphosphate- Ribose) Polymerase (PARP) Inhibitors in Ovarian Cancer, Part 1: Olaparib.
- Published in:
- Clinical Advances in Hematology & Oncology, 2016, v. 14, n. 8, p. 619
- By:
- Publication type:
- Article
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 11, p. e1532, doi. 10.1093/oncolo/oyae201
- By:
- Publication type:
- Article
PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 3, p. 1, doi. 10.3802/jgo.2022.33.e44
- By:
- Publication type:
- Article
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.
- Published in:
- Cancers, 2024, v. 16, n. 21, p. 3590, doi. 10.3390/cancers16213590
- By:
- Publication type:
- Article
The Landscape of Adoptive Cellular Therapies in Ovarian Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4814, doi. 10.3390/cancers15194814
- By:
- Publication type:
- Article
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4344, doi. 10.3390/cancers13174344
- By:
- Publication type:
- Article
Recent trends in molecular testing and maintenance targeted therapies in ovarian cancer.
- Published in:
- Obstetrician & Gynaecologist, 2023, v. 25, n. 3, p. 220, doi. 10.1111/tog.12880
- By:
- Publication type:
- Article
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2024, v. 131, n. 6, p. 848, doi. 10.1111/1471-0528.17675
- By:
- Publication type:
- Article
The role of PARP inhibitor combination therapy in ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231173183
- By:
- Publication type:
- Article